Table 3. KRAS exon 2 mutations in CD166 positive and CD166 negative CRC.
CRC | c.35G>A (G12D) | c.35G>T (G12V) | c.34G>A (G12S) | Total |
---|---|---|---|---|
CD166 positive | 18/49 (37%) | 8/49 (16%) | 3/49 (6%) | 29 |
CD166 negative | 5/21 (24%) | 2/21 (10%) | 0/21 (0.0%) | 7 |
Total | 23 | 10 | 3 | 36 |